Transcriptomics

Dataset Information

0

Expression profile after stable HIF-1a inhibition in gastric cancer cells under normoxic conditions


ABSTRACT: Based on the results of numerous clinical and preclinical analyses, the transcription factor HIF-1a has been identified as an important tumor-promoting factor and is considered to be an attractive target for cancer therapy. To further deconstruct the molecular nature of HIF-1a’s role in tumorigenesis, we have applied lentiviral shRNA transduction to establish HIF-1a-deficient gastric cancer cells. Interestingly, functional analyses failed to show a significant growth defect of HIF-1a-deficient gastric cancer cells in vitro and in vivo. These observations led us to propose that stable inactivation of HIF-1a resulted in efficient compensation enabling cell growth and, ultimately, tumor progression in a HIF-1a-independent manner. To better understand the mechanisms that control this compensation, we performed transcriptomics of control (“scrambled” (SCR)) and HIF-1a-deficient (HIF) gastric cancer cells. Analysis of hypoxia-inducible factor-1alpha (HIF-1a)-deficient gastric cancer cells under normoxia. The transcription factor HIF-1a is a key regulator of oxygen homeostasis and has been identified as an important tumor-promoting factor. Results provide insight into the role of HIF-1a in gastric carcinogenesis.

ORGANISM(S): Homo sapiens

PROVIDER: GSE57200 | GEO | 2017/02/11

SECONDARY ACCESSION(S): PRJNA245899

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2024-05-28 | GSE233772 | GEO
2022-02-24 | GSE163848 | GEO
2023-09-22 | GSE213847 | GEO
2014-05-14 | E-GEOD-55915 | biostudies-arrayexpress
2010-07-13 | E-GEOD-18478 | biostudies-arrayexpress
2014-05-14 | GSE55915 | GEO
2011-10-24 | GSE29988 | GEO
2021-05-05 | GSE164791 | GEO
2020-07-17 | GSE154584 | GEO
2020-07-17 | GSE154592 | GEO